Other News

Fourth Generation CathWorks FFRangio® System Receives Regulatory Approval in Japan

KFAR-SABA, Israel and IRVINE, Calif., Oct. 6, 2022 /PRNewswire/ — CathWorks announced today the approval of the fourth generation CathWorks FFRangio® System by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The FFRangio System is also commercially available in the United States and Europe. “The FFRangio System enables us to quickly perform a comprehensive physiologic assessment of coronary artery […]

CHS USA Inc. Acquires Medical Imaging Solutions International

OAKVILLE, ON, Oct. 6, 2022 /PRNewswire/ – CHS USA Inc., a company of Canadian Hospital Specialties Limited (CHS), completed the acquisition of Medical Imaging Solutions International. (“MISI”), effective September 16th, 2022. This acquisition will further increase CHS’ presence in the United States diagnostic imaging market. MISI and CHS are known in the healthcare industry for high quality and […]

From heart failure to heartfelt success IEHP Program Sustains Life for I.E. Woman

RANCHO CUCAMONGA, Calif., Oct. 6, 2022 /PRNewswire/ — After treatment and discharge from the emergency room (ER) for congestive heart failure complications, Inland Empire Health Plan (IEHP) member Lavinia experienced panic and anxiety attacks that compounded her heart issues and led to more hospital visits. IEHP team members identified Lavinia’s specialized needs […]

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain to treat resistant/difficult to treat hypertension and heart-failure, today announces the publication of an initiation report by Bryan […]

Genetesis Announces Close of $17.5 Million Series C Financing

Mithril Capital-led Series C to launch 5-minute noninvasive ischemia assessment requiring no pharmaceuticals, no exercise, and no radiation. MASON, Ohio–(BUSINESS WIRE)–Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing. The round was led by Mithril Capital with participation from […]

Clario bolsters executive leadership team to deliver on its long-term growth strategy

New CEO appoints two new executives and promotes senior scientist to new Chief Medical Officer position to focus company and help drive delivery of long-term growth strategy Terry Burke joins Clario as Executive Vice President of Clario’s eCOA business and David Fusco as Executive Vice President of Human Capital Dr. Todd Rudo, M.D. is promoted […]